Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

[Photobiomodulation with active oxygen and lactoferrin in the treatment of medication-related osteonecrosis of the jaw. A case report]

Clinically, soft tissue healing was observed at 30 days and 60 days and the CT scan showed hyperdense cancellous bone with well-formed cortical and no alterations.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors describe one patient with medication-related osteonecrosis of the jaw treated with minimally invasive surgery plus photobiomodulation using an 808 nm laser, along with active oxygen and lactoferrin products. The patient's pain fell from 3/10 to 0/10, and soft tissue healing and CT findings were reported at 30 and 60 days. The authors suggest the combined approach holds promise, but this is a single case report.

Who or what was studied
One 62-year-old woman with hypertension, rheumatoid arthritis and osteoporosis, treated with bisphosphonates, who developed MRONJ after tooth extraction
Wavelengths
808 nm
Limits stated in the abstract
The report describes a single patient with no control group, so the findings cannot establish whether the treatment caused the outcome.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Medication-related osteonecrosis jaw (MRONJ) affects about 5% of patients treated with bisphosphonates and other similar drugs. This case report describes the management of a case of MRONJ using photobiomodulation therapy (FBM) combined with active oxygen and lactoferrin (Blue®M). This is a 62-year-old patient with hypertension, rheumatoid arthritis and osteoporosis treated with Bonames®. After extraction, she presented exposed bone in the alveolar ridge of quadrant III. Under informed consent, minimally invasive surgery was performed with electrical instruments (Piezotome®). Histopathological analysis revealed necrotic bone tissue with chronic inflammatory infiltrate. The treatment included Blue®M teeth&bone once a day for 30 days, topical application of Blue®M gel every morning for 15 days and FBM with 808nm diode laser (Therapy-DMC®). The laser sessions were daily until day 3, and then twice a week for four weeks. The patient also performed mouthwashes with Blue®M every night for 30 days. Initially, the patient reported pain of 3/10 on the visual analog scale, which decreased to 0/10 at the end of treatment. Clinically, soft tissue healing was observed at 30 days and 60 days and the CT scan showed hyperdense cancellous bone with well-formed cortical and no alterations. Finally, this case suggests that the combination of FBM with topical active oxygen therapy and lactoferrin, along with minimally invasive surgical intervention, holds promise for the management of MRONJ.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
808nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Case report, Laser, Photobiomodulation therapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies